Vaccitech PLC, the company behind AstraZeneca Covid-19 vaccine files for US IPO

Biotech startup Vaccitech PLC is behind the Covid-19 vaccine jointly developed by AstraZeneca PLC and the University of Oxford filed on April 30, 2021, with the US regulators for an Initial Public Offering (IPO). Vaccitech PLC announced in a security filing its plans to use the technology to develop treatments for prostate cancer, hepatitis B, and human papillomavirus.  Vaccitech, started…
« Previous post: | Next post: »